6MWD 0 4 0 4 B-clinical_variable
test 5 9 5 9 I-clinical_variable
between 10 17 10 17 O
165 18 21 18 21 B-lower_bound
m 22 23 22 23 I-lower_bound
and 24 27 24 27 O
440 28 31 28 31 B-upper_bound
m 32 33 32 33 I-upper_bound
at 34 36 34 36 O
screening 37 46 37 46 O
and 47 50 47 50 O
at 51 53 51 53 O
randomization 54 67 54 67 O

Adequate 0 8 68 76 O
contraception 9 22 77 90 O
is 23 25 91 93 O
defined 26 33 94 101 O
as 34 36 102 104 O
any 37 40 105 108 O
combination 41 52 109 120 O
of 53 55 121 123 O
at 56 58 124 126 O
least 59 64 127 132 O
2 65 66 133 134 B-lower_bound
effective 67 76 135 144 O
methods 77 84 145 152 O
of 85 87 153 155 O
birth 88 93 156 161 O
control 94 101 162 169 O
, 101 102 169 170 O
of 103 105 171 173 O
which 106 111 174 179 O
at 112 114 180 182 O
least 115 120 183 188 O
1 121 122 189 190 B-lower_bound
is 123 125 191 193 O
a 126 127 194 195 O
physical 128 136 196 204 O
barrier 137 144 205 212 O

All 0 3 213 216 O
types 4 9 217 222 O
of 10 12 223 225 O
PH 13 15 226 228 B-chronic_disease
( 16 17 229 230 O
including 17 26 230 239 O
PH 27 29 240 242 B-chronic_disease
- 29 30 242 243 I-chronic_disease
IIP 30 33 243 246 I-chronic_disease
) 33 34 246 247 O

CWP 0 3 248 251 O
can 4 7 252 255 O
be 8 10 256 258 O
replaced 11 19 259 267 O
by 20 22 268 270 O
left 23 27 271 275 B-clinical_variable
ventricular 28 39 276 287 I-clinical_variable
end 40 43 288 291 I-clinical_variable
- 43 44 291 292 I-clinical_variable
diastolic 44 53 292 301 I-clinical_variable
pressure 54 62 302 310 I-clinical_variable
( 63 64 311 312 O
≤ 64 65 312 313 O
15 66 68 314 316 B-upper_bound
mmHg 69 73 317 321 I-upper_bound
) 73 74 321 322 O

Congenital 0 10 323 333 B-chronic_disease
heart 11 16 334 339 I-chronic_disease
disease 17 24 340 347 I-chronic_disease
, 24 25 347 348 O
but 26 29 349 352 O
only 30 34 353 357 O
if 35 37 358 360 O
the 38 41 361 364 O
patient 42 49 365 372 O
underwent 50 59 373 382 O
surgical 60 68 383 391 B-treatment
repair 69 75 392 398 I-treatment
more 76 80 399 403 O
than 81 85 404 408 O
one 86 89 409 412 B-lower_bound
year 90 94 413 417 I-lower_bound
before 95 101 418 424 O
enrolment 102 111 425 434 O

Connective 0 10 435 445 B-chronic_disease
tissue 11 17 446 452 I-chronic_disease
disease 18 25 453 460 I-chronic_disease
( 26 27 461 462 I-chronic_disease
CTD 27 30 462 465 I-chronic_disease
) 30 31 465 466 I-chronic_disease

Idiopathic 0 10 467 477 B-chronic_disease

Male 0 4 478 482 B-gender

Patients 0 8 483 491 O
who 9 12 492 495 O
are 13 16 496 499 O
on 17 19 500 502 O
stable 20 26 503 509 O
doses 27 32 510 515 O
of 33 35 516 518 O
a 36 37 519 520 O
PDE-5i 38 44 521 527 B-treatment
and 45 48 528 531 O
ERA 49 52 532 535 B-treatment
combination 53 64 536 547 I-treatment
therapy 65 72 548 555 I-treatment
or 73 75 556 558 O
on 76 78 559 561 O
stable 79 85 562 568 O
PDE-5i 86 92 569 575 B-treatment
monotherapy 93 104 576 587 I-treatment
6 105 106 588 589 B-upper_bound
weeks 107 112 590 595 I-upper_bound
prior 113 118 596 601 I-upper_bound
to 119 121 602 604 O
and 122 125 605 608 O
at 126 128 609 611 O
randomization 129 142 612 625 O
but 143 146 626 629 O
not 147 150 630 633 O
at 151 153 634 636 O
treatment 154 163 637 646 B-treatment
goal 164 168 647 651 O
( 169 170 652 653 O
tadalafil 170 179 653 662 B-treatment
20 180 182 663 665 B-lower_bound
to 183 185 666 668 O
40 186 188 669 671 B-upper_bound
mg 189 191 672 674 I-upper_bound
once 192 196 675 679 O
daily 197 202 680 685 O
or 203 205 686 688 O
sildenafil 206 216 689 699 B-treatment
at 217 219 700 702 O
least 220 225 703 708 O
60 226 228 709 711 B-lower_bound
mg 229 231 712 714 I-lower_bound
daily 232 237 715 720 O
dose 238 242 721 725 O
) 242 243 725 726 O

Patients 0 8 727 735 O
with 9 13 736 740 O
a 14 15 741 742 O
medical 16 23 743 750 B-chronic_disease
disorder 24 32 751 759 I-chronic_disease
, 32 33 759 760 O
condition 34 43 761 770 O
, 43 44 770 771 O
or 45 47 772 774 O
history 48 55 775 782 O

Patients 0 8 783 791 O
with 9 13 792 796 O
a 14 15 797 798 O
variance 16 24 799 807 O
of 25 27 808 810 O
more 28 32 811 815 O
than 33 37 816 820 O
15 38 40 821 823 B-lower_bound
% 40 41 823 824 I-lower_bound
between 42 49 825 832 O
the 50 53 833 836 O
screening 54 63 837 846 O
and 64 67 847 850 O
the 68 71 851 854 O
randomization 72 85 855 868 O

Patients 0 8 869 877 O
with 9 13 878 882 O
a 14 15 883 884 O
variance 16 24 885 893 O
of 25 27 894 896 O
more 28 32 897 901 O
than 33 37 902 906 O
15 38 40 907 909 B-lower_bound
% 40 41 909 910 I-lower_bound
between 42 49 911 918 O
the 50 53 919 922 O
screening 54 63 923 932 O
and 64 67 933 936 O
the 68 71 937 940 O
randomization 72 85 941 954 O
( 86 87 955 956 O
i.e. 87 91 956 960 O
, 91 92 960 961 O
baseline 93 101 962 970 O
) 101 102 970 971 O
6MWD 103 107 972 976 O
test 108 112 977 981 O

Patients 0 8 982 990 O
with 9 13 991 995 O
underlying 14 24 996 1006 O
medical 25 32 1007 1014 B-chronic_disease
disorders 33 42 1015 1024 I-chronic_disease
with 43 47 1025 1029 O
an 48 50 1030 1032 O
anticipated 51 62 1033 1044 O
life 63 67 1045 1049 B-clinical_variable
expectancy 68 78 1050 1060 I-clinical_variable
below 79 84 1061 1066 O
2 85 86 1067 1068 B-upper_bound
years 87 92 1069 1074 I-upper_bound

Portal 0 6 1075 1081 B-chronic_disease
hypertension 7 19 1082 1094 I-chronic_disease
with 20 24 1095 1099 O
liver 25 30 1100 1105 B-chronic_disease
cirrhosis 31 40 1106 1115 I-chronic_disease

Pregnant 0 8 1116 1124 B-pregnancy
women 9 14 1125 1130 B-gender
( 15 16 1131 1132 O
i.e. 16 20 1132 1136 O
, 20 21 1136 1137 O
positive 22 30 1138 1146 O
serum 31 36 1147 1152 O
ß 37 38 1153 1154 O
- 38 39 1154 1155 O
human 39 44 1155 1160 O
- 44 45 1160 1161 O
chorionic 45 54 1161 1170 O
- 54 55 1170 1171 O
gonadotropin 55 67 1171 1183 O
test 68 72 1184 1188 O
or 73 75 1189 1191 O
other 76 81 1192 1197 O
signs 82 87 1198 1203 O
of 88 90 1204 1206 O
pregnancy 91 100 1207 1216 B-pregnancy
) 100 101 1216 1217 O

Relevant 0 8 1218 1226 O
obstructive 9 20 1227 1238 B-chronic_disease
and 21 24 1239 1242 I-chronic_disease
restrictive 25 36 1243 1254 I-chronic_disease
or 37 39 1255 1257 I-chronic_disease
other 40 45 1258 1263 I-chronic_disease
lung 46 50 1264 1268 I-chronic_disease
diseases 51 59 1269 1277 I-chronic_disease

Women 0 5 1278 1283 B-gender
of 6 8 1284 1286 O
childbearing 9 21 1287 1299 O
potential 22 31 1300 1309 O
must 32 36 1310 1314 O
agree 37 42 1315 1320 B-contraception_consent
to 43 45 1321 1323 I-contraception_consent
use 46 49 1324 1327 I-contraception_consent
adequate 50 58 1328 1336 I-contraception_consent
contraception 59 72 1337 1350 I-contraception_consent
when 73 77 1351 1355 O
sexually 78 86 1356 1364 O
active 87 93 1365 1371 O

active 0 6 1372 1378 O
cancer 7 13 1379 1385 B-cancer
disease 14 21 1386 1393 O
with 22 26 1394 1398 O
localized 27 36 1399 1408 O
and/or 37 43 1409 1415 O
metastasized 44 56 1416 1428 B-cancer
tumor 57 62 1429 1434 I-cancer
mass 63 67 1435 1439 I-cancer

breast 0 6 1440 1446 O
feeding 7 14 1447 1454 O
women 15 20 1455 1460 B-gender

combined 0 8 1461 1469 O
oral 9 13 1470 1474 B-contraception_consent
contraceptives 14 28 1475 1489 I-contraception_consent

coronary 0 8 1490 1498 B-chronic_disease
heart 9 14 1499 1504 I-chronic_disease
disease 15 22 1505 1512 I-chronic_disease
or 23 25 1513 1515 O
stroke 26 32 1516 1522 B-chronic_disease
within 33 39 1523 1529 O
previous 40 48 1530 1538 B-upper_bound
3 49 50 1539 1540 I-upper_bound
months 51 57 1541 1547 I-upper_bound

orthopedic 0 10 1548 1558 B-chronic_disease
disease 11 18 1559 1566 I-chronic_disease
, 18 19 1566 1567 O
peripheral 20 30 1568 1578 B-chronic_disease
artery 31 37 1579 1585 I-chronic_disease
occlusive 38 47 1586 1595 I-chronic_disease
disease 48 55 1596 1603 I-chronic_disease
, 55 56 1603 1604 O
which 57 62 1605 1610 O
affects 63 70 1611 1618 O
the 71 74 1619 1622 O
patient 75 82 1623 1630 O
's 82 84 1630 1632 O
ability 85 92 1633 1640 O
to 93 95 1641 1643 O
walk 96 100 1644 1648 O

